L H Ospina1, G C Nitzburg1, M Shanahan1, M M Perez-Rodriguez1, E Larsen1, A Latifoglu1, K E Burdick2. 1. Icahn School of Medicine at Mount Sinai, Departments of Psychiatry and Neuroscience, New York, NY, USA. 2. Icahn School of Medicine at Mount Sinai, Departments of Psychiatry and Neuroscience, New York, NY, USA; James J. Peters VA Medical Center, Bronx, NY, USA; Brigham and Women's Hospital, Department of Psychiatry, Boston, MA, USA. Electronic address: Katherine.burdick@mssm.edu.
Abstract
BACKGROUND: Schizophrenia (SZ) studies suggest that neurocognition predicts functional outcome and that social cognition mediates this relationship. Bipolar disorder (BD) patients also have cognitive, social, and functional impairments but the relationship among these factors in BD is not well established. We assessed whether social cognition modulates the influence of neurocognition on community functioning in BD, as found in SZ. METHODS: 200 BD patients and 49 healthy controls (HC) were administered and compared on a battery of tests assessing neurocognition, social cognition, and community functioning. We conducted a series of regression analyses to investigate potential mediation or moderation of social cognition on the relationship between neurocognition and community functioning. RESULTS: BD patients performed worse on neurocognitive domains of processing speed, attention, verbal learning, and global neurocognition. Also, BD patients performed worse on theory of mind, the social cognition composite score, and community functioning. Neurocognition did not significantly predict functional outcome in our BD sample. However, we found a moderating effect of social cognition: among patients with poor social cognition, better neurocognition was associated with better community functioning, a relationship not seen in BD patients with good social cognition. LIMITATIONS: The study was limited by a relatively small HC group and assessing one subtype of functioning status. CONCLUSIONS: The relationship between neurocognition and community functioning in BD may be dependent on social cognition status, implying the presence of social cognitive heterogeneity. Results may be relevant to choosing proper treatment interventions depending on the patient's social cognitive level.
BACKGROUND:Schizophrenia (SZ) studies suggest that neurocognition predicts functional outcome and that social cognition mediates this relationship. Bipolar disorder (BD) patients also have cognitive, social, and functional impairments but the relationship among these factors in BD is not well established. We assessed whether social cognition modulates the influence of neurocognition on community functioning in BD, as found in SZ. METHODS: 200 BD patients and 49 healthy controls (HC) were administered and compared on a battery of tests assessing neurocognition, social cognition, and community functioning. We conducted a series of regression analyses to investigate potential mediation or moderation of social cognition on the relationship between neurocognition and community functioning. RESULTS: BD patients performed worse on neurocognitive domains of processing speed, attention, verbal learning, and global neurocognition. Also, BD patients performed worse on theory of mind, the social cognition composite score, and community functioning. Neurocognition did not significantly predict functional outcome in our BD sample. However, we found a moderating effect of social cognition: among patients with poor social cognition, better neurocognition was associated with better community functioning, a relationship not seen in BD patients with good social cognition. LIMITATIONS: The study was limited by a relatively small HC group and assessing one subtype of functioning status. CONCLUSIONS: The relationship between neurocognition and community functioning in BD may be dependent on social cognition status, implying the presence of social cognitive heterogeneity. Results may be relevant to choosing proper treatment interventions depending on the patient's social cognitive level.
Authors: Anne-Kathrin J Fett; Wolfgang Viechtbauer; Maria-de-Gracia Dominguez; David L Penn; Jim van Os; Lydia Krabbendam Journal: Neurosci Biobehav Rev Date: 2010-07-08 Impact factor: 8.989
Authors: Lucy J Robinson; Jill M Thompson; Peter Gallagher; Utpal Goswami; Allan H Young; I Nicol Ferrier; P Brian Moore Journal: J Affect Disord Date: 2006-03-06 Impact factor: 4.839
Authors: Junghee Lee; Lori Altshuler; David C Glahn; David J Miklowitz; Kevin Ochsner; Michael F Green Journal: Am J Psychiatry Date: 2013-03 Impact factor: 18.112
Authors: Rafael Tabarés-Seisdedos; Vicente Balanzá-Martínez; José Sánchez-Moreno; Anabel Martinez-Aran; José Salazar-Fraile; Gabriel Selva-Vera; Cristina Rubio; Ignacio Mata; Manuel Gómez-Beneyto; Eduard Vieta Journal: J Affect Disord Date: 2008-03-04 Impact factor: 4.839
Authors: A Martinez-Aran; E Vieta; C Torrent; J Sanchez-Moreno; J M Goikolea; M Salamero; G S Malhi; A Gonzalez-Pinto; C Daban; S Alvarez-Grandi; K Fountoulakis; G Kaprinis; R Tabares-Seisdedos; J L Ayuso-Mateos Journal: Bipolar Disord Date: 2007 Feb-Mar Impact factor: 6.744
Authors: Roscoe O Brady; Adam Beermann; Madelaine Nye; Shaun M Eack; Raquelle Mesholam-Gately; Matcheri S Keshavan; Kathryn E Lewandowski Journal: Front Psychiatry Date: 2020-11-04 Impact factor: 4.157
Authors: Verónica Romero-Ferreiro; Lorena García-Fernández; Ana Isabel Aparicio; Isabel Martínez-Gras; Mónica Dompablo; Luis Sánchez-Pastor; David Rentero; Miguel Ángel Alvarez-Mon; Juan Manuel Espejo-Saavedra; Guillermo Lahera; Paloma Marí-Beffa; José Luis Santos; Roberto Rodriguez-Jimenez Journal: J Clin Med Date: 2022-04-06 Impact factor: 4.241